Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 677 press releases before 2019
-
AstraZeneca to invest £120 million in new manufacturing facility to produce Zoladex in Macclesfield
-
Marc Dunoyer appointed Chief Financial Officer of AstraZeneca
-
AstraZeneca PLC third quarter and nine months results 2013
-
AstraZeneca advances MedImmune’s benralizumab to Phase III in severe asthma
-
US appeals court issues decision in PULMICORT RESPULES patent litigation
-
AstraZeneca announces proposal to close Brixham Environmental Laboratory
-
AstraZeneca initiates phase III clinical programme for selumetinib, a treatment in development for patients with advanced or metastastic non-small-cell lung cancer
-
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability
-
AstraZeneca enters co-promotion agreement with Janssen in Japan for innovative prostate cancer treatment
-
MedImmune Completes Acquisition of Amplimmune
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director Global Media Relations (Oncology)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
